Skip to content

Blood BDNF levels differ in Parkinson’s disease, with major variation across studies

A research synthesis found lower blood levels of brain-derived neurotrophic factor (BDNF) in Parkinson’s disease, but results varied substantially and did not establish a usable clinical test.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

Across the pooled studies, people with Parkinson’s disease had lower blood BDNF levels than healthy controls. Lower serum levels were also associated with cognitive impairment. However, serum levels did not differ significantly by depression status, and spinal-fluid levels did not differ significantly between patients and controls. None of these findings establishes clinical usefulness.

Keep in mind

Results varied substantially across studies (heterogeneity statistic I2 = 97.0%). Subgroup findings suggested closer applicability to serum samples and Asian populations. The abstract did not establish diagnostic accuracy.

THE NUMBERS, WITH CONTEXT

What researchers found

-1.037 standard deviations

Peripheral blood BDNF concentration

Parkinson’s disease versus healthy controls; standardized mean difference, 95% CI [-1.412, -0.662]. Measurement timing was not reported in the abstract.

Front Aging Neurosci, 2025 · Original source ↓

What the pooled difference represents

The standardized difference describes the group gap in standard-deviation units: units based on how much measurements vary. The negative sign indicates lower blood BDNF in the Parkinson’s group, not a percentage change.

A possible marker needs more study

The association with cognitive impairment makes BDNF a candidate for further research. The abstract does not show that measuring it can reliably identify cognitive problems in an individual or guide treatment decisions.

CHECK THE ORIGINAL

The original publication

Association of brain-derived neurotrophic factor in blood and cerebrospinal fluid with Parkinson's disease and non-motor symptoms of Parkinson's disease: a systematic review and meta-analysis of 6655 participants.

Zhao Z, Sun J, Liu Y et al.
Front Aging Neurosci · 2025

PubMed ID
41049535
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.